For the year ending 2025-12-31, CNTX has $68,493,768 in assets. $8,020,041 in debts. $65,995,228 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 65,995,228 | |||
| Prepaid expenses and other current assets | 2,358,474 | |||
| Total current assets | 68,353,702 | |||
| Operating lease right-of-use asset | 110,410 | |||
| Property and equipment, net | 29,656 | |||
| Total assets | 68,493,768 | |||
| Accounts payable | 2,532,887 | |||
| Accrued expenses and other current liabilities | 5,375,090 | |||
| Operating lease liability - current | 112,064 | |||
| Total current liabilities | 8,020,041 | |||
| Operating lease liabilities - non-current | 0 | |||
| Total liabilities | 8,020,041 | |||
| Common stock0.001 par value 200,000,000 shares authorized 91,879,177 and 89,704,194 issued and outstanding at december31, 2025 and december 31, 2024, respectively | 91,879 | |||
| Additional paid-in capital | 191,285,157 | |||
| Accumulated deficit | -130,903,309 | |||
| Total stockholders' equity | 60,473,727 | |||
| Total liabilities and stockholders' equity | 68,493,768 | |||
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)